Author

HU Ren-ming

University of PennsylvaniaORCID 0000-0002-7742-2602Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Aimin LiuiD· 1 shared Donald M. O’RourkeiD· 1 shared Eric W. Barr· 1 shared Jiasong LiiD· 1 shared Joseph Martin Bollinger Jr.iD· 1 shared Katelyn A. BustiniD· 1 shared Kelly HicksiD· 1 shared Kirill A. MartemyanoviD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Aimin LiuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastoma

Kyosuke Shishikura, Jiasong Li, Yiming Chen, Nate R. McKnight, Thomas P. Keeley, Katelyn A. Bustin, Eric W. Barr, Snehil R. Chilkamari, Mahaa Ayub, Sun Woo Kim, Zongtao Lin, HU Ren-ming, Kelly Hicks, Xie Wang, Donald M. O’Rourke, , Megan L. Matthews

This paper identifies hydralazine as an inhibitor of cysteamine dioxygenase (ADO), showing its role in treating preeclampsia and inducing senescence in glioblastoma.

Science Advances · Oct 15, 2025Peer-reviewedBiochemistry